Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Liberty Media Series A
FWONA
$23.7B
| $2.93M | ﹤0.01% |
93,608
+9,144
| +11% | +$274K |
|
2027
Greif Class B
GEF.B
$4.22B
| $2.91M | ﹤0.01% |
44,600
+7,600
| +21% | +$512K |
|
|
MTGE
2028
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $2.91M | ﹤0.01% |
173,793
+72,741
| +72% | +$1.19M |
|
|
TSG
2029
DELISTED
The Stars Group Inc.
TSG
| $2.9M | ﹤0.01% |
+170,800
| New | +$2.5M |
|
2030
Altisource Portfolio Solutions
ASPS
$65.6M
| $2.9M | ﹤0.01% |
9,850
-3,625
| -27% | -$803K |
|
2031
SFL Corp
SFL
$1.61B
| $2.9M | ﹤0.01% |
+197,132
| New | +$2.93M |
|
2032
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $2.88M | ﹤0.01% |
44,300
+11,200
| +34% | +$724K |
|
2033
Grupo SIMEC
SIM
$4.68B
| $2.88M | ﹤0.01% |
223,000
+11,300
| +5% | +$154K |
|
2034
James Hardie Industries
JHX
$17.9B
| $2.87M | ﹤0.01% |
181,900
+600
| +0.3% | +$9.26K |
|
|
OSB
2035
DELISTED
Norbord Inc.
OSB
| $2.87M | ﹤0.01% |
100,800
+48,900
| +94% | +$1.34M |
|
2036
Noodles & Co
NDLS
$100M
| $2.87M | ﹤0.01% |
62,425
+12,950
| +26% | +$437K |
|
|
WILN
2037
DELISTED
Wi-LAN Inc.
WILN
| $2.86M | ﹤0.01% |
1,564,500
+251,800
| +19% | +$443K |
|
2038
Lennar Class B
LEN.B
$20.7B
| $2.85M | ﹤0.01% |
73,074
-34,981
| -32% | -$1.25M |
|
2039
Vitamin Cottage Natural Grocers
NGVC
$646M
| $2.84M | ﹤0.01% |
273,600
-88,700
| -24% | -$1.06M |
|
2040
Clarus
CLAR
$145M
| $2.83M | ﹤0.01% |
522,512
-106,572
| -17% | -$596K |
|
2041
Upland Software
UPLD
$17.9M
| $2.83M | ﹤0.01% |
17,820
+6,520
| +58% | +$790K |
|
2042
STRATTEC Security
STRT
$338M
| $2.83M | ﹤0.01% |
101,621
-3,650
| -3% | -$120K |
|
|
CWEI
2043
DELISTED
Clayton Williams Energy, Inc.
CWEI
| $2.82M | ﹤0.01% |
21,372
-86,600
| -80% | -$11.6M |
|
|
GURE
2044
Gulf Resources
GURE
$5.48M
| $2.82M | ﹤0.01% |
31,680
-876
| -3% | -$88.7K |
|
2045
OFG Bancorp
OFG
$2.26B
| $2.82M | ﹤0.01% |
238,870
-51,083
| -18% | -$650K |
|
|
AFAM
2046
DELISTED
Almost Family Inc
AFAM
| $2.82M | ﹤0.01% |
58,000
-43,000
| -43% | -$2.06M |
|
|
KEYW
2047
DELISTED
The KEYW Holding Corporation
KEYW
| $2.82M | ﹤0.01% |
298,326
-25,574
| -8% | -$264K |
|
|
2048
Greif
GEF
$5.03B
| $2.81M | ﹤0.01% |
51,000
+900
| +2% | +$50K |
|
|
BOJA
2049
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $2.81M | ﹤0.01% |
136,900
-136,725
| -50% | -$2.73M |
|
|
BLCM
2050
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $2.8M | ﹤0.01% |
22,720
+14,430
| +174% | +$1.89M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.